Added-value of SPECT/CT to lymphatic mapping and sentinel lymphadenectomy in gynaecological cancers
Identifieur interne : 005746 ( Ncbi/Curation ); précédent : 005745; suivant : 005747Added-value of SPECT/CT to lymphatic mapping and sentinel lymphadenectomy in gynaecological cancers
Auteurs : Tarik Z. Belhocine [Canada] ; Michel Prefontaine [Canada] ; Dominique Lanvin [Canada] ; Monique Bertrand [Canada] ; Irina Rachinsky [Canada] ; Helen Ettler [Canada] ; Pamela Zabel [Canada] ; Larry W. Stitt [Canada] ; Akira Sugimoto [Canada] ; Jean-Luc Urbain [Canada]Source :
- American Journal of Nuclear Medicine and Molecular Imaging [ 2160-8407 ] ; 2013.
Abstract
Lymphatic mapping and sentinel lymphadenectomy (LM/SL) have been successfully used in pre-treatment nodal staging of gynaecological cancers. We hypothesised the added-value of LM/SL plus SPECT/CT in patients with early stage of cervical cancer and vulvar cancer. A prospective, single-center, diagnostic, open label, active control, non-randomized clinical trial has been conducted in 7 patients with FIGO IA-IB1 cervical cancer and 7 patients with FIGO stage I-II-IIIcN0 vulvar cancer. All patients underwent LM/SL plus SPECT/low-dose CT and complete lymph node dissection (CLND) according to the standard of care. In case of negative hematoxylin-eosin staining, serial sections of the SLNs were analysed by immunohistochemistry and high molecular weight cytokeratin. Primary outcome measures were the detection rate, the sensitivity (SV), the negative predictive value (NPV), the diagnostic accuracy (DA) for anatomic localisation of SLNs, and the impact on management of SPECT/CT guided LM/SL versus CLND. The secondary outcome measure was the patient tolerability and operating time of LM/SL guided SPECT/CT versus CLND. http://clinicaltrials.gov/show/NCT00773071 All 14 patients were enrolled into the 1-day research protocol with dual-tracer LM/SL and SPECT/CT. Additional SLNs were detected on SPECT/CT compared to conventional planar imaging. Hot and cold > 1cm SLNs were detected on SPECT/CT. Detection rate, SV, NPV, DA were 100% in both groups; false negative rate was 0%. Rate of SLN metastases was 28.5% in cervical cancer and 42.9% in vulvar cancer. Impact on treatment was 28.5% and 14.3% in cervical cancer and vulvar cancer patients, respectively. SPECT/CT was well tolerated by all patients and operating time for LM/SL was within 30 min. No adverse events were reported with a time frame of 1-to-3 years. In early stage of gynaecological cancers, SPECT/low-dose CT is technically feasible and of clinical added-value for LM/SL.
Url:
PubMed: 23526734
PubMed Central: 3601478
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002B60
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :002B59
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002525
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :005746
Links to Exploration step
PMC:3601478Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Added-value of SPECT/CT to lymphatic mapping and sentinel lymphadenectomy in gynaecological cancers</title>
<author><name sortKey="Belhocine, Tarik Z" sort="Belhocine, Tarik Z" uniqKey="Belhocine T" first="Tarik Z" last="Belhocine">Tarik Z. Belhocine</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Department of Medical Imaging-Nuclear Medicine, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Prefontaine, Michel" sort="Prefontaine, Michel" uniqKey="Prefontaine M" first="Michel" last="Prefontaine">Michel Prefontaine</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Department of Gynaecology Oncology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lanvin, Dominique" sort="Lanvin, Dominique" uniqKey="Lanvin D" first="Dominique" last="Lanvin">Dominique Lanvin</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Department of Gynaecology Oncology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bertrand, Monique" sort="Bertrand, Monique" uniqKey="Bertrand M" first="Monique" last="Bertrand">Monique Bertrand</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Department of Gynaecology Oncology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rachinsky, Irina" sort="Rachinsky, Irina" uniqKey="Rachinsky I" first="Irina" last="Rachinsky">Irina Rachinsky</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Department of Medical Imaging-Nuclear Medicine, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ettler, Helen" sort="Ettler, Helen" uniqKey="Ettler H" first="Helen" last="Ettler">Helen Ettler</name>
<affiliation wicri:level="1"><nlm:aff id="au3"><institution>Department of Pathology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zabel, Pamela" sort="Zabel, Pamela" uniqKey="Zabel P" first="Pamela" last="Zabel">Pamela Zabel</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Department of Medical Imaging-Nuclear Medicine, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stitt, Larry W" sort="Stitt, Larry W" uniqKey="Stitt L" first="Larry W" last="Stitt">Larry W. Stitt</name>
<affiliation wicri:level="1"><nlm:aff id="au4"><institution>Statistical Services</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sugimoto, Akira" sort="Sugimoto, Akira" uniqKey="Sugimoto A" first="Akira" last="Sugimoto">Akira Sugimoto</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Department of Gynaecology Oncology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Urbain, Jean Luc" sort="Urbain, Jean Luc" uniqKey="Urbain J" first="Jean-Luc" last="Urbain">Jean-Luc Urbain</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Department of Medical Imaging-Nuclear Medicine, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">23526734</idno>
<idno type="pmc">3601478</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601478</idno>
<idno type="RBID">PMC:3601478</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">002B60</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002B60</idno>
<idno type="wicri:Area/Pmc/Curation">002B59</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002B59</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002525</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002525</idno>
<idno type="wicri:Area/Ncbi/Merge">005746</idno>
<idno type="wicri:Area/Ncbi/Curation">005746</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Added-value of SPECT/CT to lymphatic mapping and sentinel lymphadenectomy in gynaecological cancers</title>
<author><name sortKey="Belhocine, Tarik Z" sort="Belhocine, Tarik Z" uniqKey="Belhocine T" first="Tarik Z" last="Belhocine">Tarik Z. Belhocine</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Department of Medical Imaging-Nuclear Medicine, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Prefontaine, Michel" sort="Prefontaine, Michel" uniqKey="Prefontaine M" first="Michel" last="Prefontaine">Michel Prefontaine</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Department of Gynaecology Oncology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lanvin, Dominique" sort="Lanvin, Dominique" uniqKey="Lanvin D" first="Dominique" last="Lanvin">Dominique Lanvin</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Department of Gynaecology Oncology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bertrand, Monique" sort="Bertrand, Monique" uniqKey="Bertrand M" first="Monique" last="Bertrand">Monique Bertrand</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Department of Gynaecology Oncology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rachinsky, Irina" sort="Rachinsky, Irina" uniqKey="Rachinsky I" first="Irina" last="Rachinsky">Irina Rachinsky</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Department of Medical Imaging-Nuclear Medicine, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ettler, Helen" sort="Ettler, Helen" uniqKey="Ettler H" first="Helen" last="Ettler">Helen Ettler</name>
<affiliation wicri:level="1"><nlm:aff id="au3"><institution>Department of Pathology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zabel, Pamela" sort="Zabel, Pamela" uniqKey="Zabel P" first="Pamela" last="Zabel">Pamela Zabel</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Department of Medical Imaging-Nuclear Medicine, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stitt, Larry W" sort="Stitt, Larry W" uniqKey="Stitt L" first="Larry W" last="Stitt">Larry W. Stitt</name>
<affiliation wicri:level="1"><nlm:aff id="au4"><institution>Statistical Services</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sugimoto, Akira" sort="Sugimoto, Akira" uniqKey="Sugimoto A" first="Akira" last="Sugimoto">Akira Sugimoto</name>
<affiliation wicri:level="1"><nlm:aff id="au2"><institution>Department of Gynaecology Oncology, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Urbain, Jean Luc" sort="Urbain, Jean Luc" uniqKey="Urbain J" first="Jean-Luc" last="Urbain">Jean-Luc Urbain</name>
<affiliation wicri:level="1"><nlm:aff id="au1"><institution>Department of Medical Imaging-Nuclear Medicine, Western University</institution>
<addr-line>London, ON, Canada</addr-line>
</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>London, ON</wicri:regionArea>
<wicri:noRegion>ON</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">American Journal of Nuclear Medicine and Molecular Imaging</title>
<idno type="eISSN">2160-8407</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Lymphatic mapping and sentinel lymphadenectomy (LM/SL) have been successfully used in pre-treatment nodal staging of gynaecological cancers. We hypothesised the added-value of LM/SL plus SPECT/CT in patients with early stage of cervical cancer and vulvar cancer. A prospective, single-center, diagnostic, open label, active control, non-randomized clinical trial has been conducted in 7 patients with FIGO IA-IB1 cervical cancer and 7 patients with FIGO stage I-II-IIIcN0 vulvar cancer. All patients underwent LM/SL plus SPECT/low-dose CT and complete lymph node dissection (CLND) according to the standard of care. In case of negative hematoxylin-eosin staining, serial sections of the SLNs were analysed by immunohistochemistry and high molecular weight cytokeratin. Primary outcome measures were the detection rate, the sensitivity (SV), the negative predictive value (NPV), the diagnostic accuracy (DA) for anatomic localisation of SLNs, and the impact on management of SPECT/CT guided LM/SL versus CLND. The secondary outcome measure was the patient tolerability and operating time of LM/SL guided SPECT/CT versus CLND. http://clinicaltrials.gov/show/NCT00773071 All 14 patients were enrolled into the 1-day research protocol with dual-tracer LM/SL and SPECT/CT. Additional SLNs were detected on SPECT/CT compared to conventional planar imaging. Hot and cold > 1cm SLNs were detected on SPECT/CT. Detection rate, SV, NPV, DA were 100% in both groups; false negative rate was 0%. Rate of SLN metastases was 28.5% in cervical cancer and 42.9% in vulvar cancer. Impact on treatment was 28.5% and 14.3% in cervical cancer and vulvar cancer patients, respectively. SPECT/CT was well tolerated by all patients and operating time for LM/SL was within 30 min. No adverse events were reported with a time frame of 1-to-3 years. In early stage of gynaecological cancers, SPECT/low-dose CT is technically feasible and of clinical added-value for LM/SL.</p>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005746 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 005746 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:3601478 |texte= Added-value of SPECT/CT to lymphatic mapping and sentinel lymphadenectomy in gynaecological cancers }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:23526734" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |